[Conversion from typical to atypical neuroleptics. Guidelines for ambulatory and inpatient treatment]

Standard

[Conversion from typical to atypical neuroleptics. Guidelines for ambulatory and inpatient treatment]. / Lambert, Martin; Moritz, Steffen; Haasen, C; Naber, Dieter.

in: NERVENARZT, Jahrgang 71, Nr. 11, 11, 2000, S. 859-875.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{c138e7d5fd984f749897c6c0c4ad4a4a,
title = "[Conversion from typical to atypical neuroleptics. Guidelines for ambulatory and inpatient treatment]",
abstract = "The introduction of atypical antipsychotics has presented new options for the pharmacological treatment of schizophrenic patients. It is assumed that in the near future, neuroleptic medication will shift from conventional to atypical antipsychotics for an increasing number of patients. The present article addresses guidelines for the conversion from conventional to atypical neuroleptics in inpatient and outpatient settings.",
author = "Martin Lambert and Steffen Moritz and C Haasen and Dieter Naber",
year = "2000",
language = "Deutsch",
volume = "71",
pages = "859--875",
journal = "NERVENARZT",
issn = "0028-2804",
publisher = "Springer",
number = "11",

}

RIS

TY - JOUR

T1 - [Conversion from typical to atypical neuroleptics. Guidelines for ambulatory and inpatient treatment]

AU - Lambert, Martin

AU - Moritz, Steffen

AU - Haasen, C

AU - Naber, Dieter

PY - 2000

Y1 - 2000

N2 - The introduction of atypical antipsychotics has presented new options for the pharmacological treatment of schizophrenic patients. It is assumed that in the near future, neuroleptic medication will shift from conventional to atypical antipsychotics for an increasing number of patients. The present article addresses guidelines for the conversion from conventional to atypical neuroleptics in inpatient and outpatient settings.

AB - The introduction of atypical antipsychotics has presented new options for the pharmacological treatment of schizophrenic patients. It is assumed that in the near future, neuroleptic medication will shift from conventional to atypical antipsychotics for an increasing number of patients. The present article addresses guidelines for the conversion from conventional to atypical neuroleptics in inpatient and outpatient settings.

M3 - SCORING: Zeitschriftenaufsatz

VL - 71

SP - 859

EP - 875

JO - NERVENARZT

JF - NERVENARZT

SN - 0028-2804

IS - 11

M1 - 11

ER -